To determine if models were based on tumor-type independent, pathologically identifiable, and biologically relevant information, blinded pathology review was performed on subsets of CPTAC and TCGA cases with and without TP53, PTEN, or STK11 mutations. The gene discussed is PTEN; the disease is neoplasm.